0001209191-23-038753.txt : 20230621
0001209191-23-038753.hdr.sgml : 20230621
20230621160515
ACCESSION NUMBER: 0001209191-23-038753
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230616
FILED AS OF DATE: 20230621
DATE AS OF CHANGE: 20230621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flynn Daniel Lee
CENTRAL INDEX KEY: 0001713712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 231029812
MAIL ADDRESS:
STREET 1: C/O DECIPHERA PHARMACEUTICALS, INC.
STREET 2: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-16
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001713712
Flynn Daniel Lee
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
0
1
0
0
Chief Scientific Officer
0
Common Stock
2023-06-16
4
S
0
1655
14.4018
D
57158
D
Common Stock
180947
I
By Daniel L. Flynn Revocable Trust
Common Stock
91020
I
By Daniel L. Flynn Irrevocable Trust
Common Stock
49488
I
By GRAT
This sale was to cover tax liabilities in the vesting of restricted stock units.
Reflects shares previously transferred from the Daniel L. Flynn Revocable Trust to the Reporting Person's grantor retained annuity trust.
/s/ Jeffrey M. Held, Attorney-in-Fact
2023-06-21